Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Interchangeability of Infanrix™ IPV/Hib and Pediacel® at 2,4 & 6 Months of Age

This study has been completed.
Sponsor:
Collaborators:
IWK Health Centre
Sanofi Pasteur MSD
Information provided by:
Dalhousie University
ClinicalTrials.gov Identifier:
NCT00990080
First received: October 5, 2009
Last updated: June 14, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
No publications provided by Dalhousie University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):